| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910809671803321 |
|
|
Titolo |
New arrhythmia technologies / / edited by Paul J. Wang ... [et al.] |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Malden, Mass., : Blackwell Futura, 2005 |
|
|
|
|
|
|
|
ISBN |
|
1-281-32022-6 |
9786611320225 |
0-470-76303-5 |
0-470-98872-X |
0-470-99420-7 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (306 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Arrhythmia - Treatment - Technological innovations |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
New Arrhythmia Technologies; Contents; List of Contributors; Preface; Part I: Advances in antiarrhythmic pharmacologic therapy; 1 New antiarrhythmic pharmacologic therapies and regulatory issues in antiarrhythmic drug development; 2 New frontiers in antithrombotic therapy for atrial fibrillation; Part II: Future of antiarrhythmic therapy; 3 Principles of pharmacogenomics: Focus on arrhythmias; 4 The cardiac sodium-channel carboxy terminus: predicted and detected structure provide a novel target for antiarrhythmic drugs development |
5 Embryonic stem-cell-derived cardiomyocytes as a model for arrhythmia 6 Gene and cell therapy for sinus and AV nodal dysfunction; 7 Gene therapy for cardiac tachyarrhythmias; Part III: Monitoring, noninvasive mapping, risk assessment, and external defibrillation; 8 New developments in noninvasive rhythm monitoring, implantable hemodynamic monitoring, functional status monitoring and noninvasive mapping; 9 Techniques of prediction of arrhythmia occurrence and stratification for sudden cardiac death |
10 Beta-blocker efficacy in long-QT syndrome patients with mutations in the pore and nonpore regions of the hERG potassiumchannel gene 11 New developments in out-of-hospital cardiac defibrillation: evaluation of AED strategies; Part IV: Advances in pacing; 12 Sensor |
|
|
|
|
|
|
|
|
|
|
|
and sensor integration; 13 New electrode and lead designs for pacemakers; 14 Current concepts in intravascular pacemaker and defibrillator lead extraction; 15 Left ventricular epicardial lead implantation: Anatomy, techniques, and tools; 16 New resynchronization lead systems and devices; 17 New indications for pacing |
Part V: Advances in implantable defibrillators 18 Implantable defibrillator sensing and discrimination algorithms; 19 Arrhythmia prevention and termination algorithms; 20 New lead designs and lead-less systems; 21 Optimization of defibrillation function; 22 Remote web-based device monitoring; 23 New ICD indications; Part VI: Advances in catheter surgical ablation; 24 Advances in surgical ablation devices for atrial fibrillation; 25 Epicardial access: present and future applications for interventional electrophysiologists; 26 Advances in catheter control devices |
27 Advances in energy sources in catheter ablation28 New ablation paradigms: Anatomic ablation of complex arrhythmia substrates; Index |
|
|
|
|
|
|
Sommario/riassunto |
|
New Arrhythmia Technologies provides a complete discussion of recent, emerging, and future arrhythmia technologies. This forward-thinking book details successful trials and investigates areas of research that have not yet reached the trial phase. The elite panel of authors have explored fresh information on:advances in antiarrhythmic pharmacologis therapy advances in monitoring, risk assessment, and noninvasive mapping advances in pacing therapy advances in implantable defibrillators advances in catheter and surgical ablation |
|
|
|
|
|
|
|
| |